1. Home
  2. SPRY vs SA Comparison

SPRY vs SA Comparison

Compare SPRY & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • SA
  • Stock Information
  • Founded
  • SPRY 2015
  • SA 1979
  • Country
  • SPRY United States
  • SA Canada
  • Employees
  • SPRY N/A
  • SA N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • SA Precious Metals
  • Sector
  • SPRY Health Care
  • SA Basic Materials
  • Exchange
  • SPRY Nasdaq
  • SA Nasdaq
  • Market Cap
  • SPRY 1.1B
  • SA 1.1B
  • IPO Year
  • SPRY N/A
  • SA N/A
  • Fundamental
  • Price
  • SPRY $14.08
  • SA $12.27
  • Analyst Decision
  • SPRY Strong Buy
  • SA
  • Analyst Count
  • SPRY 4
  • SA 0
  • Target Price
  • SPRY $26.00
  • SA N/A
  • AVG Volume (30 Days)
  • SPRY 1.4M
  • SA 573.3K
  • Earning Date
  • SPRY 03-20-2025
  • SA 11-14-2024
  • Dividend Yield
  • SPRY N/A
  • SA N/A
  • EPS Growth
  • SPRY N/A
  • SA N/A
  • EPS
  • SPRY N/A
  • SA N/A
  • Revenue
  • SPRY $2,568,000.00
  • SA N/A
  • Revenue This Year
  • SPRY $66,750.00
  • SA N/A
  • Revenue Next Year
  • SPRY $508.63
  • SA N/A
  • P/E Ratio
  • SPRY N/A
  • SA N/A
  • Revenue Growth
  • SPRY 8460.00
  • SA N/A
  • 52 Week Low
  • SPRY $6.13
  • SA $9.31
  • 52 Week High
  • SPRY $18.51
  • SA $20.55
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 71.29
  • SA 48.16
  • Support Level
  • SPRY $11.00
  • SA $11.84
  • Resistance Level
  • SPRY $12.48
  • SA $12.35
  • Average True Range (ATR)
  • SPRY 0.85
  • SA 0.40
  • MACD
  • SPRY 0.42
  • SA 0.17
  • Stochastic Oscillator
  • SPRY 95.43
  • SA 68.12

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

Share on Social Networks: